Data/Laikas
Data - 28/01/2021
17:00 - 18:45
One of the main novelties of Horizon Europe will be the implementation of high-ambition missions aiming at promoting more impactful research results while engaging citizens in a common European goal. Their implementation is challenging as they must remain focused, time-bound, guaranteeing cross-sector fertilisation and cutting-edge innovation. In addition, robust governance and control mechanisms will have to be put in place.
Cancer has been identified as one of the five key mission areas as it remains one of the major societal challenges. If current trends continue, 1.67 million people in the EU will die from cancer by 2030, representing a significant burden for patients and their families, healthcare systems and society. Beating cancer will require a multidisciplinary and comprehensive approach, relying on both discoveries in basic research and faster translation into practice, besides efficient coordination of all relevant stakeholders (researchers, policymakers, industry, patient organisations). The granularity of the European research landscape and the current fragmentation of public research and health policies constitute a colossal trial for the Cancer Mission’s success.
The Mission Cancer Report was delivered in September 2020.
At this webinar MEP Maria da Graça Carvalho and Professor Walter Ricciardi, Chair of the Mission Board on Cancer, and Dr Tina Bregant, Head of the Cabinet of the Slovenian Minister for Health, will join lead academic scientists, policy makers and patient representatives who will speak about how to implement this ambitious plan.
Discussion will be open and will include topics such as prevention, new therapeutic approaches, faster translation and patient care.
Programme overview
Welcome and Introduction: Ronald de Bruin (Director at COST Association)
Perspective from Policy Makers:
- An EU mission on cancer, what to look for? (Maria da Graça Carvalho, Member of the European Parliament)
- The Slovenian priorities regarding health and the EU presidency (Tina Bregant, Head of the Cabinet of the Ministry of Health, Slovenia)
- The EU mission on cancer, current status and future outlook (Walter Ricciardi, Università Cattolica del Sacro Cuore in Rome and Chair of the EU Mission on Cancer)
Input and Open Debate with COST Actions and Stakeholders representatives:
- Matti Aapro (European CanCer Organisation)
- Chrissie Brierley (Joint Programming Initiative – A Healthy Diet for a Healthy Life)
- Kjersti Flatmark (Oslo University Hospital and Chair of a COST Action dealing with a rare cancer)
- Daniel Ortega (Imdea Nanociencia and leader of a COST Action on magnetic hyperthermia for cancer therapy)
- Chiara Riganti (University of Torino and leader of a COST Action multidrug resistant tumours)
Event Moderator: Toni Andreu (European Infrastructure for Translational Medicine)
Join us at this webinar (passcode: 020363) and get actively engaged!
If you have any questions, please contact COST Science Officers Dr Federica Ortelli and Dr Mafalda Quintas.
Dalintis per…
